Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GATE I: Sodium Oxybate vs Oxazepam in Alcohol Withdrawal
NCT02090504Phase 4Completed
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- Feb 2002
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of sodium oxybate in alcohol withdrawal syndrome (AWS), sponsored by Università Cattolica del Sacro Cuore. Started Feb 2002; status: completed.
02
Drugs
sodium oxybate
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT02090504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02090504.